Financière de Tubize SA (TUB.BR) Stock Price
€154 0.1%
to add to portfolio
AI Score

-
Alternative
3 -
Fundamental
6 -
Technical
6
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Financière de Tubize SA, AI stock picks, stock alerts and much more.
TUB.BR AI Stock Analysis
AI stock analysis for TUB.BR is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Financière de Tubize SA (TUB.BR) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Financière de Tubize SA (TUB.BR) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Financière de Tubize SA (TUB.BR), currently trading at €154, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About TUB.BR

-
Financière de Tubize SA, through its interest in UCB, operates as a biopharmaceutical company worldwide.
-
Symbol
TUB.BR
-
Market
EURONEXT
-
Industry
Biotechnology
-
Market Cap
6.9B
Similar Stocks
![]() |
Valneva SE VLA.PA |
€3.78 2.1% |
3 |
![]() |
OSE Immunotherapeutics SA OSE.PA |
€7.07 4.1% |
4 |
![]() |
UCB SA UCB.BR |
€189.8 0.2% |
7 |
![]() |
Innate Pharma S.A. IPH.PA |
€1.9 1.1% |
2 |
![]() |
Pharming Group PHARM.AS |
€0.8375 0.5% |
5 |
TUB.BR Alternative Data
Web Traffic
Financière de Tubize SA receives an estimated 1517 monthly visitors to financiere-tubize.be, which is up by 29.5% over the last month.
-
Web Traffic
1517
-
Change from Previous Month
29.5%
-
3 Month Change
42%
News Mentions
Financière de Tubize SA was mentioned 0 times in the news yesterday.
-
News Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Job Postings
Financière de Tubize SA currenly has an estimated 0 open job postings.
-
Job Postings
0
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
LinkedIn Employees
According to LinkedIn, Financière de Tubize SA has 12 employees.
-
LinkedIn Employees
12
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
71.4%
TUB.BR Financials
TUB.BR Key Metrics
-
Total Revenue
€32
-
Net Income
€92.9M
-
Earnings per Share
€2.09
-
Free cash flow
-€806
-
EBITDA
-€878.5K
-
EBITDA Ratio
-27454.4
-
Total Assets
€1.9B
TUB.BR 2-year Revenue & Income
TUB.BR 2-year Free Cash Flow
TUB.BR Technicals
TUB.BR SMA
TUB.BR RSI
FAQ
What's the current price of Financière de Tubize SA (TUB.BR) Stock?
The price of an Financière de Tubize SA (TUB.BR) share is €154.
What's the market cap of Financière de Tubize SA?
The current market cap of Financière de Tubize SA is 6.9B.
Should I buy or sell TUB.BR?
Financière de Tubize SA shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Financière de Tubize SA is better viewed as a hold or accumulate position while waiting for further developments.
Is Financière de Tubize SA a good investment?
The current analysis of Financière de Tubize SA's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Financière de Tubize SA's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Financière de Tubize SA (TUB.BR) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Financière de Tubize SA stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Financière de Tubize SA (TUB.BR) that investors often compare it to?
Financière de Tubize SA (TUB.BR) is often compared to similar stocks such as Valneva SE, OSE Immunotherapeutics SA, UCB SA, Innate Pharma S.A. and Pharming Group.
What is the forecast for Financière de Tubize SA's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Financière de Tubize SA's stock price to be around €151.1 in 2026. Starting from the current price of €154, this represents a 1.9% change in price, indicating a neutral outlook for the stock.
How to buy Financière de Tubize SA (TUB.BR) Stock?
Financière de Tubize SA stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Financière de Tubize SA shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.